Author

M. Dolan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:host-pathogen & immune response· 2 Organism:bacteria (other)· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

J. M. L. Ebos· 2 shared A. B. Westbye· 1 shared A. Dommer· 1 shared A. E. Frosch· 1 shared A. Kannan· 1 shared A. McKenery· 1 shared A. P. Arora· 1 shared A. Srinivasan· 1 shared

Activity by Year

2021-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. M. L. Ebos

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

IL-15 complex-induced IL-10 enhances Plasmodium-specific CD4+ Tfh differentiation and antibody production

M. Bravo, T. Dileepan, M. Dolan, J. Hildebrand, J. Wolford, S. E. Hamilton, A. E. Frosch, K. S. Burrack

This study shows that IL-15 complex treatment increases IL-10 in NK cells, which promotes Tfh differentiation and antibody production against Plasmodium, improving survival from reinfection.

bioRxiv · Oct 6, 2023 · PreprintImmunology

Robust eIF4B levels undermine invasive growth and immune evasion mechanisms in murine triple negative breast cancer models.

R. Smith, L. Z. D. Z. D. Diba, A. Srinivasan, R. A. Zollo, T. Ossevoort, Q. He, S. H. Colligan, M. Dolan, Y. Vedire, T. Sultana, M. Venkatesh, A. P. Arora, S. Gawlak, D. Washington, C. Brackett, , S. E. Walker

This study shows that higher eIF4B levels in murine triple negative breast cancer models are linked to less aggressive tumor growth and better patient outcomes.

bioRxiv · Sep 16, 2022 · PreprintCancer Biology

Genomic diversity of bacteriophages infecting Rhodobacter capsulatus and their relatedness to its gene transfer agent RcGTA

J. Rapala, B. Miller, M. Garcia, M. Dolan, M. Bockman, M. Hansson, D. A. Russell, R. A. Garlena, S. G. Cresawn, A. B. Westbye, J. T. Beatty, R. Alvey, D. W. Bollivar

This study characterizes 26 new bacteriophages infecting Rhodobacter capsulatus, revealing genomic diversity and relationships to RcGTA.

bioRxiv · Aug 4, 2021Microbiology

CYP1B1 converts procarcinogens into genotoxins in Saccharomyces cerevisiae

M. Fasullo, N. Perpetua, A. Kannan, M. Dolan

This study shows that CYP1B1 converts carcinogens into genotoxins in yeast, increasing DNA damage and translocations but not mutations.

bioRxiv · Jul 22, 2021Pharmacology & Toxicology

Acquired resistance to PD-L1 inhibition is associated with an enhanced type I IFN-stimulated secretory program in tumor cells

Y. Shi, M. Dolan, M. Mastri, A. McKenery, J. W. Hill, A. Dommer, S. Benzekry, M. Long, S. Abrams, I. Puzanov, J. M. L. Ebos

This study identifies an IFN-stimulated secretory program in PD-L1-resistant tumors that promotes immune evasion and shows that targeting this program can inhibit tumor growth.

bioRxiv · Jul 1, 2021 · PreprintCancer Biology